The growth in the human vaccines market is driven by several factors, including the increasing prevalence of infectious diseases, rising global health awareness, and advancements in vaccine research and development. Enhanced funding and investments by governments and global health organizations to eliminate infectious diseases contribute significantly to the expansion and innovation within the vaccine sector. The COVID-19 pandemic has particularly highlighted the critical role of vaccines in global health security, leading to unprecedented public and private partnerships focused on vaccine development and distribution.
Moreover, demographic factors such as aging populations and the rise in chronic health conditions that increase susceptibility to infections necessitate continued vaccine development and uptake. Together, these dynamics underscore the vital role of vaccines in contemporary medicine and public health, ensuring ongoing investment and research in this essential field.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Intramuscular & Subcutaneous Administration Route segment, which is expected to reach US$58.7 Billion by 2030 with a CAGR of a 7.8%. The Oral Administration Route segment is also set to grow at 5.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $11.7 Billion in 2023, and China, forecasted to grow at an impressive 11.8% CAGR to reach $16.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Human Vaccines Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Human Vaccines Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Human Vaccines Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as ALK - Abelló A/S, Altimmune, Inc., Astellas Pharma Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 16 Featured):
- ALK - Abelló A/S
- Altimmune, Inc.
- Astellas Pharma Inc.
- Bavarian Nordic A/S
- Bharat Biotech
- BiondVax Pharmaceuticals Ltd.
- GlaxoSmithKline Plc
- Hualan Biological Engineering Inc.
- Janssen Pharmaceuticals Inc.
- MedImmune
- Mitsubishi Tanabe Pharma
- Pfizer Inc.
- Sanofi Pasteur SA
- Seqirus
- Serum Institute of India Pvt. Ltd.
- SK BioScience
- Takeda Pharmaceutical Company Limited
- Zydus Cadila
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ALK - Abelló A/S
- Altimmune, Inc.
- Astellas Pharma Inc.
- Bavarian Nordic A/S
- Bharat Biotech
- BiondVax Pharmaceuticals Ltd.
- GlaxoSmithKline Plc
- Hualan Biological Engineering Inc.
- Janssen Pharmaceuticals Inc.
- MedImmune
- Mitsubishi Tanabe Pharma
- Pfizer Inc.
- Sanofi Pasteur SA
- Seqirus
- Serum Institute of India Pvt. Ltd.
- SK BioScience
- Takeda Pharmaceutical Company Limited
- Zydus Cadila
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 262 |
Published | October 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 43.5 Billion |
Forecasted Market Value ( USD | $ 71.4 Billion |
Compound Annual Growth Rate | 7.3% |
Regions Covered | Global |